Text Message Reminders Increase Second Dose of Flu Vaccinations in Children
Embedding educational information further boosts rates
December 29, 2014—Researchers at Columbia University Medical Center's Mailman School of Public Health and College of Physicians and Surgeons (P&S) studied the impact of text message reminders for the second dose of influenza vaccine required for many young children to protect them against the virus. The findings showed that sending text message reminders both increased receipt of the second dose of the vaccine by the end of the season and brought children in sooner to be vaccinated. When educational information on the importance of the second dose of influenza vaccine was embedded in the text messages, there was an even greater effect than with conventional text messages that only told families when and where to go, or with written reminder only. The results are published online in the journal Pediatrics.
The randomized controlled trial was conducted during the 2012–13 influenza season in three community-based pediatric clinics affiliated with NewYork-Presbyterian Hospital/Columbia University Medical Center in Northern Manhattan. Children from 660 families who were in need of a second dose of influenza vaccine that season took part in the intervention. Most families were Latino and publicly insured; nearly three-quarters (71.9 percent) thought that their child was at least somewhat protected from influenza after one dose.
The children, who ranged in age from 6 months through 8-years-old, were assigned to one of three groups: “educational” text message, “conventional” text message, or “written reminder-only.” All families had a cell phone with text messaging capabilities. A written reminder with next dose due date was given to all families at the time of the child’s first influenza vaccination.
The results showed that children in the educational text message reminder group were significantly more likely to receive a second dose of influenza vaccine (72.7 percent) than those in the conventional text message reminder group (66.7 percent) or the written reminder-only group (57.1 percent).
“Text message programs like these allow health care providers to care for their patients even when they are not in front of them in the office, somewhat like a modern-day house call,” said principal investigator Melissa Stockwell, MD, MPH, assistant professor of population and family health at the Mailman School of Public Health and assistant professor of pediatrics at P&S.
Parents reported liking the text messages and saw them as helpful because they acted as a reminder, provided information in a quick way that did not require talking with anyone, and demonstrated that someone “cared.” Nearly two-thirds (60.8 percent) of parents reported the reminder was either the main reason or part of the reason they brought their child for a second dose, and 70.1 percent said that it affected bringing their child sooner. Parents also noted they would recommend the text messages to other parents.
Influenza vaccine coverage overall is low among young children; those in need of two doses in a given season are at particular risk, with less than half of those who receive the first dose returning to receive the second dose. Dr. Stockwell equates this to wearing half a bicycle helmet.
Timeliness of vaccination is also key, as many children who need two doses are not fully protected until two weeks after receipt of the second dose.
“Even in children who ultimately receive two doses in a season, the time interval between doses is often beyond the recommended 28 days,” said Dr. Stockwell. “This leaves many unprotected when the virus begins circulating.”
Earlier studies have showed that traditional strategies like mail or telephone have not been effective among urban, low-income families—the same population that is at high risk for under-vaccination.
A previous paper by Dr. Stockwell and colleagues looked at the impact of text messaging reminders for first-dose influenza vaccination rates in pediatric and adolescent populations. Results of the study showed that message reminders for early childhood vaccination were widely supported.
This randomized controlled trial provides valuable information for establishing best practices for influenza vaccine text message reminders. Important next steps will be to assess the impact of text message vaccine reminders in other populations, as well as for other vaccines.
The study was supported by the National Institutes of Health/National Cancer Institute (KM1 CA156709). The authors report no conflicts of interest.
About Columbia University’s Mailman School of Public Health Founded in 1922, Columbia University’s Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its over 450 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,300 graduate students from more than 40 nations pursuing a variety of master’s and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including ICAP (formerly the International Center for AIDS Care and Treatment Programs) and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu
Stephanie Berger 212-305-4372 email@example.com
This article originally appeared on the Mailman School of Public Health website.